By Dr Charlotte Rose Lemech

Preprints

Thoms JAI; Yan F; Hampton H; Davidson S; Joshi S; Saw J; Sarowar C; Lim XY; Nunez A; Kakadia P; Bhuyan GS; Zou X; Nguyen M; Ghodousi E; Koch F; Vafaee F; Pickford R; Raftery M; Hough S; Buckland G; Bailey M; Ghodke Y; Absar N; Vaughan L; Pasalic L; Fong C; Kenealy M; Hiwase D; Stoddart R; Mohammed S; Lee L; Passam F; Larsen S; Spring K; Skarratt K; Rebeiro P; Presgrave P; Stevenson W; Ling S; Tiley C; Fuller S; Roncolato F; Enjeti A; Hoenemann D; Lemech C; Jolly C; Bohlander S; Curtis D; Wong J; Unnikrishnan A; Hertzberg M; Olivier J; Polizzotto M; Pimanda J, 2024, Clinical Response to Azacitidine in Myelodysplastic Neoplasms is Associated with Distinct DNA Methylation Changes in Haematopoietic Stem and Progenitor cellsin vivo, http://dx.doi.org/10.1101/2024.07.19.24310679

Gavagna G; Clifton-Bligh R; Lemech C; Williams S; Elefantis E; Nair H; Farrugia A, 2020, Intravenous Immunoglobulin Rich in Neutralising Antibodies to SARS-CoV-2 as a Passive Immunity Modality in Healthy Individuals at Risk of Infection With COVID-19: Study Protocol for an Open Label, Active Control Phase 1/2 Study., http://dx.doi.org/10.21203/rs.3.rs-137186/v1

Back to profile page